The AGPS gene gives your body instructions to make plasmalogens, special fats that help cell membranes work normally, especially in the brain, eyes, bones, and nerves. If this gene does not work properly, plasmalogen levels drop and a child can develop rhizomelic chondrodysplasia punctata type 3, a rare condition that affects growth, movement, breathing, vision, and development. This gene plays an important role in how cells build and maintain these fats inside peroxisomes (small cell compartments).
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
AGPSGene function
What if the gene works
The AGPS gene helps your cells make plasmalogens, a special type of fat. These fats support cell membranes and are especially important in the brain, nerves, eyes, and heart.
Risk
What if the gene does not work
Pathogenic variants in the AGPS gene can cause a rare condition with short limbs, cataracts, stiff joints, and delayed development. Milder and more severe variants can change which features appear, when they start, and how strongly they affect daily life.
Treatment
What does that mean for your treatment
No treatment or drug selection approach tied to the AGPS gene is currently established. Care is based on symptom directed support rather than a medicine chosen because of this gene change. Research on the AGPS gene is exploring plasmalogen related therapies, but these approaches remain early stage.
Conditions associated with AGPS
Gene function
What if the gene works
Many everyday cell tasks depend on special fats that help membranes stay stable and responsive. A central part of the AGPS gene's role in ether lipid production happens inside peroxisomes, small cell compartments that handle certain fat processing jobs. These fats are then used across the body as part of healthy cell membranes.
Inside peroxisomes (small cell compartments that process certain fats), the AGPS gene changes an early fat building block into the form needed for ether lipids. This is a key step in making plasmalogens and related membrane fats.
Ether lipids made with help from the AGPS gene become part of cell membranes throughout the body. They help membranes keep the right balance of structure and flexibility for everyday cell activity.
These membrane fats also help organize the cell surface so signals can pass in a controlled way. That supports steady communication between cells and the normal movement of materials across membranes.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal human differences, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the AGPS gene show how variants influence the AGPS gene's function by changing the enzyme’s shape, stability, or transport to peroxisomes, the cell compartments where it works. Some variants leave partial activity, while others sharply reduce or eliminate activity and lower plasmalogen production, an important membrane fat. When variants in the AGPS gene cause rhizomelic chondrodysplasia punctata, this functional range can shape how early features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the AGPS gene cause rhizomelic chondrodysplasia punctata type 3, a rare inherited condition that starts early in life. Information about the AGPS gene and rhizomelic chondrodysplasia punctata type 3 centers on this well-established link. People with this diagnosis may have short stature, joint stiffness, cataracts, and developmental delay, although features can vary. Finding two disease-causing variants in the AGPS gene, one from each parent, can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For AGPS, risk is mainly shaped by inheritance: a child usually develops an AGPS-related condition only after inheriting two nonworking copies, one from each parent. Having a family history of the condition or a known AGPS variant can raise the chance of being a carrier, while lifestyle factors are not known to meaningfully change this risk.
Inheritance of AGPS variants
AGPS-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one AGPS gene variant from each parent, and both copies need to carry a disease-causing variant for the condition to develop. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In practical terms, how AGPS gene variants are inherited usually involves variants being passed quietly through families until a child inherits both changed copies.
What does my AGPS result mean for my family?
For AGPS, family impact is usually discussed in terms of an inherited condition passed down in a recessive way. Parents of a child with an AGPS-related condition are often healthy carriers, and brothers and sisters may also be carriers or may be affected. Close relatives may want to learn whether the same gene change runs in the family, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for AGPS gene variants usually uses a blood or saliva sample. A lab reads the DNA code in the AGPS gene, often through a multigene panel or exome test, to look for variants that can confirm an inherited condition when symptoms fit. It can also clarify carrier status in families.
When should I consider getting a genetic test?
Genetic testing for the AGPS gene can be worth considering when a baby or child has signs of a rare inherited condition that affects bone growth, eye health, and development, or when this condition runs in the family. It may also help clarify carrier status for relatives after an AGPS change has already been found.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they reveal depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another processes it faster, so the same treatment can work differently from person to person. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It looks at gene drug patterns to better understand why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the AGPS gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so general concerns about symptoms, treatment, or medication side effects are best discussed with your doctor or pharmacist.